Skip to content

Randomized, parallel controlled clinical trial of the occurrence, prevention and treatment of radioactive oral mucositis

Randomized, parallel controlled clinical trial of the occurrence, prevention and treatment of radioactive oral mucositis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027470
Enrollment
Unknown
Registered
2019-11-14
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radioactive oral mucositis

Interventions

experimental group:Free radical scavenger
control group:Normal saline

Sponsors

Liaoning Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: KPS score is greater than 70, age: 18-70 years old. Can understand the situation of this study and sign informed consent (informed consent).

Exclusion criteria

Exclusion criteria: 1. Patients who received systemic chemotherapy for more than 5 cycles before enrollment (4 cycles are still eligible for enrollment). 2. History of malignant tumors in other areas, excluding curable non-melanoma skin cancer and cervical carcinoma in situ. 3. Pregnancy and lactation patients. 4. There is currently an infection, but the infection can be controlled after admission. 5. Uncontrollable diabetes - an optional blood glucose > 200mg% (mmmol /L), but if the patient's blood glucose > 200mg%, fasting blood glucose <140mg% (9.17mmol /L), the patient can be included; 6. Liver and kidney dysfunction; 7. Other serious diseases, such as myocardial infarction within 6 months; 8. People with a history of mental illness that is difficult to control; 9. The investigator believes that it is not appropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
HIF-1a;COX;SOD;POD;CAT;Pain index;Ulcer classification;Microecological analysis;

Secondary

MeasureTime frame
Oral humidity;Saliva volume and composition;

Countries

China

Contacts

Public ContactYingqiu Song

Liaoning Cancer Hospital

1018501023@qq.com+86 18900917411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026